关注
KEISUKE KIDA
KEISUKE KIDA
聖マリアンナ医科大学 薬理学
在 marianna-u.ac.jp 的电子邮件经过验证
标题
引用次数
引用次数
年份
Time-to-furosemide treatment and mortality in patients hospitalized with acute heart failure
Y Matsue, K Damman, AA Voors, N Kagiyama, T Yamaguchi, S Kuroda, ...
Journal of the American College of Cardiology 69 (25), 3042-3051, 2017
3352017
CTX-M-27- and CTX-M-14-producing, ciprofloxacin-resistant Escherichia coli of the H30 subclonal group within ST131 drive a Japanese regional ESBL epidemic
Y Matsumura, JR Johnson, M Yamamoto, M Nagao, M Tanaka, ...
Journal of Antimicrobial Chemotherapy 70 (6), 1639-1649, 2015
1392015
Reversible ventricular dysfunction takotsubo cardiomyopathy
YJ Akashi, H Musha, K Kida, K Itoh, K Inoue, K Kawasaki, N Hashimoto, ...
European Journal of Heart Failure 7 (7), 1171-1176, 2005
1372005
Effects of Additive Tolvaptan vs. Increased Furosemide on Heart Failure With Diuretic Resistance and Renal Impairment―Results From the K-STAR Study―
T Inomata, Y Ikeda, K Kida, Y Shibagaki, N Sato, Y Kumagai, ...
Circulation Journal 82 (1), 159-167, 2017
702017
Effect of optimizing guideline-directed medical therapy before discharge on mortality and heart failure readmission in patients hospitalized with heart failure with reduced …
T Yamaguchi, T Kitai, T Miyamoto, N Kagiyama, T Okumura, K Kida, ...
The American journal of cardiology 121 (8), 969-974, 2018
582018
Effects of ACE2 inhibition in the post-myocardial infarction heart
MA Kim, D Yang, K Kida, N Molotkova, SJ Yeo, N Varki, M Iwata, ...
Journal of cardiac failure 16 (9), 777-785, 2010
552010
Risk stratification of patients with cardiac sarcoidosis: the ILLUMINATE-CS registry
T Nabeta, T Kitai, Y Naruse, T Taniguchi, K Yoshioka, H Tanaka, ...
European Heart Journal 43 (36), 3450-3459, 2022
462022
The exercise training effects of skeletal muscle strength and muscle volume to improve functional capacity in patients with myocardial infarction
K Kida, N Osada, YJ Akashi, H Sekizuka, K Omiya, F Miyake
International journal of cardiology 129 (2), 180-186, 2008
442008
Reversible ventricular dysfunction (takotsubo cardiomyopathy) following polymorphic ventricular tachycardia.
YJ Akashi, K Nakazawa, K Kida, S Ryu, A Takagi, R Kishi, T Kunishima, ...
The Canadian journal of cardiology 19 (4), 449-451, 2003
432003
Clinical and prognostic values of ALBI score in patients with acute heart failure
Y Matsue, N Kagiyama, T Yamaguchi, S Kuroda, T Okumura, K Kida, ...
Heart, Lung and Circulation 29 (9), 1328-1337, 2020
422020
Diurnal blood pressure variation in patients with sleep apnea syndrome
K Nagata, N Osada, M Shimazaki, K Kida, K Yoneyama, A Tsuchiya, ...
Hypertension Research 31 (2), 185-191, 2008
382008
Relationship between sleep apnea syndrome and sleep blood pressure in patients without hypertension
H Sekizuka, K Kida, YJ Akashi, K Yoneyama, N Osada, K Omiya, ...
Journal of cardiology 55 (1), 92-98, 2010
372010
Influence of exercise-induced pulmonary hypertension on exercise capacity in asymptomatic degenerative mitral regurgitation
K Suzuki, M Izumo, K Yoneyama, K Mizukoshi, R Kamijima, S Kou, ...
Journal of Cardiology 66 (3), 246-252, 2015
342015
Prognostic value of BNP reduction during hospitalization in patients with acute heart failure
N Kagiyama, T Kitai, A Hayashida, T Yamaguchi, T Okumura, K Kida, ...
Journal of cardiac failure 25 (9), 712-721, 2019
322019
Palliative care in patients with advanced heart failure
K Kida, S Doi, N Suzuki
Heart failure clinics 16 (2), 243-254, 2020
312020
Influence of gender and types of sports training on QT variables in young elite athletes
K Omiya, H Sekizuka, K Kida, K Suzuki, YJ Akashi, H Ohba, H Musha
European journal of sport science 14, S32-S38, 2014
302014
Respiratory muscle strength in relation to sarcopenia in elderly cardiac patients
KP Izawa, S Watanabe, K Oka, Y Kasahara, Y Morio, K Hiraki, Y Hirano, ...
Aging clinical and experimental research 28, 1143-1148, 2016
292016
Efficacy of tolvaptan added to furosemide in heart failure patients with advanced kidney dysfunction: a pharmacokinetic and pharmacodynamic study
K Kida, Y Shibagaki, N Tominaga, N Matsumoto, YJ Akashi, F Miyake, ...
Clinical pharmacokinetics 54, 273-284, 2015
292015
Coronavirus Disease 2019 (COVID-19) Information for Cardiologists―Systematic Literature Review and Additional Analysis―
T Sugimoto, A Mizuno, T Kishi, N Ito, C Matsumoto, M Fukuda, ...
Circulation Journal 84 (6), 1039-1043, 2020
282020
The relation between Geriatric Nutritional Risk Index and muscle mass, muscle strength, and exercise capacity in chronic heart failure patients
KP Izawa, S Watanabe, Y Hirano, S Yamamoto, K Oka, N Suzuki, K Kida, ...
International journal of cardiology 177 (3), 1140-1141, 2014
272014
系统目前无法执行此操作,请稍后再试。
文章 1–20